Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2020

View Archived Issues

AD and HHV: Still a mystery

Glial cells contribute to brain control of aging

New phase III trial evaluates MK-6482 in advanced renal cell carcinoma

Genetic removal of mast cell Tph1 protects mice from developing obesity and insulin resistance

FDA approves Dificid for C. difficile infection in children age 6 months and older

FDA clears NeoImmuneTech's IND to study NT-I7 plus pembrolizumab in advanced solid tumors

Otsuka reports promising topline data from Japanese trials of fremanezumab in migraine

LNA-anti-miR-150 ameliorates FSGS in vivo

Targeting SK1 overcomes resistance to immune checkpoint inhibitors in melanoma

Retinoic X receptor as therapeutic target for poststroke recovery

Vallon Pharmaceuitcals presents results on manipulated dextroamphetamine sulfate

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Gilead describes new IDO-1 inhibitors

Novartis Inflammasome Research describes new NLRP3 inflammasome inhibitors

New CRLF2 ligands identified at Korea University Research and Business Foundation

GeoVax and BravoVax sign letter of intent to codevelop 2019-nCoV coronavirus vaccine

FDA approves Trijardy XR for type 2 diabetes

miR-3064-5p found to have prognostic value in HCC

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Sichuan Kelun-Biotech Biopharmaceutical discloses RORC agonists

FDA clears INDs for Surface Oncology's antibody candidates SRF-617 and SRF-388

Study suggests direct amino acid toxicity could account for caloric restriction benefits

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...